Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States.

Karelehto, EveliinaBrouwer, LiekeBenschop, KimberleyKok, JenBasile, KerriMcMullan, BrendanRawlinson, WilliamDruce, JulianNicholson, SuellenSelvarangan, RangarajHarrison, ChristopherLankachandra, Kamanivan Eijk, HettyKoen, Gerritde Jong, MennoPajkrt, DasjaWolthers, Katja C2019-03-222019-03-222019-01-011080-60593056131810.3201/eid2501.180352http://hdl.handle.net/10029/622955Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.enAustraliaPicornavirusesUnited Statesneutralizing antibodyoutbreakparechovirus A3seroepidemiologyseroprevalencethe NetherlandsvirusesSeroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States.ArticleEmerg Infect Dis 2019; 25(1):148-52